Access the full text.
Sign up today, get DeepDyve free for 14 days.
R.P. Abratt, W.R. Bezwoda, G. Falkson (1994)
Efficacy and safety profile of gemcitabine in advanced non-small cell lung cancer: a phase II studyJ Clin Oncol, 12
M. Krzakowski, M. Wenczl, T. Brodowicz, V. Tzekova, R. Ramlau, N. Ghilezan, B. Čučević, E. Ulsperger, C. Zielinski, M. Zwitter (2004)
Gemcitabine and cisplatin (GC) +/- subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)Journal of Clinical Oncology, 22
C. T. Le, A. Brown, P. Fitzgerald (2003)
Gemcitabine in the treatment of advanced non-small cell lung cancer: a meta-analysis of survival outcomesLung Cancer, 41
R. Rudd, N. Gower, L. James, W. Gregory, T. Eisen, S. Lee, P. Harper, S. Spiro (2002)
Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC)
P. Barradas, M. Melo, M. Cristóvão, Agostinho Costa, A. Alves (2003)
P-526 Gemcitabine (G) or vinorelbine (V)? What's the best drug in combination with a platinum-derivative for the treatment of locally advanced and metastatic non small cell lung cancer (NSCLC)? A 6 years retrospective studyLung Cancer, 41
A. Sandler, J. Nemunaitis, C. Denham, J. Pawel, Y. Cormier, U. Gatzemeier, K. Mattson, C. Manegold, M. Palmer, A. Gregor, B. Nguyen, C. Niyikiza, L. Einhorn (2000)
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 1
R. Abratt, W. Bezwoda, G. Falkson, L. Goedhals, D. Hacking, T. Rugg (1994)
Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 12 8
P. Zatloukal, L. Petruželka, M. Zemanova, V. Kolek, J. Skřičková, M. Pešek, H. Fojtů, I. Grygárková, D. Sixtová, J. Roubec, Eva Horenková, L. Havel, P. Prusa, L. Novakova, T. Skácel, M. Kůta (2003)
Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.Lung cancer, 41 3
J. Pujol, J. Breton, A. Rivière, P. Rebattu, A. Depierre, X. Quantin, J. Morère, B. Milleron, D. Debieuvre, P. Souquet (2003)
O-222 Gemcitabine-Docetaxel (GD) versus Vinorelbine-Cisplatin (VC) in advanced non-small cell lung cancer (NSCLC). A phase III studyLung Cancer, 41
C. Sederholm, G. Hillerdal, K. Lamberg, K. Kölbeck, M. Dufmats, R. Westberg, S. Gawande (2005)
Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 33
V. Georgoulias, G. Samonis, E. Papadakis, A. Alexopoulos, X. Tsiafaki, A. Rapti, M. Veslemes, T. Grigoratou, P. Palamidas, C. Kouroussis, D. Mavroudis, S. Kakolyris, T. Giannakakis, J. Vlachonikolis (2001)
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.Lung cancer, 34 Suppl 4
M. Krzakowski, M. Wenczl, T. Brodowicz, V. Tzekova, R. Ramlau, N. Ghilezan, B. Čučević, E. Ulsperger, C. Zielinski, M. Zwitter (2003)
Gemcitabine and cisplatin (GC) +/- subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 14_suppl
M. Krzakowski, M. Wenczl, T. Brodowicz (2003)
Gemcitabine and Cisplatin (GC) +/− subsequent maintenance therapy with single agent gemcitabine in advanced non-small cell lung cancer (NSCLC): preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)Lung Cancer, 41
E. Cortesi, L. Trodella, F. Nelli, R. D'Angelillo, G. D'Auria, S. Ramella, C. Fonzo, A. Ceratti (2003)
P-236 Induction chemotherapy (CT) with gemcitabine (G), paclitaxel (T), and cisplatin (P) and subsequent radiotherapy (TRT) with concomitant G for stage IIIB non-small cell lung cancer (NSCLC): results of a multicenter phase II studyLung Cancer, 41
J. Schiller, D. Harrington, C. Belani, C. Langer, A. Sandler, J. Krook, Junming Zhu, David Johnson (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.The New England journal of medicine, 346 2
C. Sederholm (2002)
Gemcitabine (G) compared with gemcitabine plus carboplatin in advanced non-small cell lung cancer (NSCLC): a phase III study by the Swedish Lung Cancer Study Group (SLUSG)Proc Am Soc Clin Oncol, 21
U. Gatzemeier, F. Shepherd, T. Chevalier, P. Weynants, B. Cottier, H.J.M. Groen, R. Rosso, K. Mattson, H. Cortés-Funes, M. Tonato, R. Burkes, M. Gottfried, M. Voi (1996)
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study.European journal of cancer, 32A 2
A. Paccagnella, A. Favaretto, F. Oniga, A. Bearz, M. Clerici, F. Barbieri, A. Riccardi, M. Ghi, R. Biason, S. Tumolo (2003)
O-92 Paclitaxel/carboplatin (PC) vs paclitaxel/carboplatin/gemcitabine (PCG) in advanced NSCLC: Preliminary results of an ongoing phase II–III multicentric studyLung Cancer, 41
P. Zatloukal, L. Petruželka, M. Zemanova, V. Kolek, J. Skřičková, M. Pešek, D. Sixtová, M. Roubec, L. Havel, P. Prusa (2003)
Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized TrialLung Cancer, 41
R. Lilenbaum, P. Bonomi, M. Socinski (2003)
O-6 Phase II randomized trial of irinotecan/docetaxel (ID) or irinotecan/gemcitabine (IG) with or without celecoxib in second-line non-small cell lung cancer (NSCLC) — preliminary resultsLung Cancer, 41
Review of current data on gemcitabine (Gemzar®) in non-small cell lung cancer
American Journal of Cancer – Springer Journals
Published: Aug 10, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.